Too Hot? Too Cold? When Is it "Just Right" to Stop Dual Antiplatelet Therapy After PCI With DES?

JACC Cardiovasc Interv. 2017 Aug 28;10(16):1631-1632. doi: 10.1016/j.jcin.2017.07.004.

Authors

Jay Giri¹, Ashwin Nathan²

Affiliations

¹ Cardiovascular Medicine Division, Penn Cardiovascular Outcomes, Quality, & Evaluative Research Center, Philadelphia, Pennsylvania. Electronic address: [email protected].
² Cardiovascular Medicine Division, Penn Cardiovascular Outcomes, Quality, & Evaluative Research Center, Philadelphia, Pennsylvania.

PMID: 28838472
DOI: 10.1016/j.jcin.2017.07.004

No abstract available

Keywords: PCI; dual antiplatelet therapy.

Publication types

Editorial
Comment

MeSH terms

Aspirin
Clopidogrel*
Data Analysis
Humans
Platelet Aggregation Inhibitors*
Ticlopidine

Substances

Platelet Aggregation Inhibitors
Clopidogrel
Ticlopidine
Aspirin